Additionally, we tested anti-ATIC-autoantibody biomarker and conventional biomarker AFP simultaneously in the patient’s sera and suggested that the combinational measurement of two biomarkers generated by different mechanisms can enhance the diagnostic accuracy in cancer. The gene discussed is ATIC; the disease is cancer.